Bridgeway Capital Management, LLC Standard Biotools Inc. Transaction History

Bridgeway Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.93 - $1.52 $46,500 - $76,000	50,000 Added 30.86%	212,000 $248,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $2.06 $178,200 - $333,720	162,000 New	162,000 $178,000
Q2 2019 Aug 14, 2019	SELL	$11.49 - $14.17 $631,318 - $778,570	-54,945 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$8.47 - $14.36 $962,420 - $1.63 Million	-113,627 Reduced 67.41%	54,945 $730,000
Q1 2018 May 15, 2018	BUY	$5.75 - $7.97 $546,250 - $757,150	95,000 Added 129.13%	168,572 $984,000
Q4 2017 Feb 14, 2018	SELL	$4.46 - $6.45 $312,200 - $451,500	-70,000 Reduced 48.76%	73,572 $433,000
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.49 $509,680 - $788,210	143,572	143,572 $724,000

142

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $144M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.